The section of the Affordable Care Act, which calls for the creation of the biosimilar pathway, was recently upheld by the Supreme Court.  While not as headline-worthy as the news surrounding the individual mandate, the fact that the Biologics Price Competition and Innovation Act (BPCIA) provision survived the process was significant for the biotech world. Biologics are some of the best treatment options for serious medical conditions such as cancer, autoimmune ...

Read more...

1 Pages

Most Popular